These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Current status of complete remission rate of acute leukemia in Shanghai].
    Author: Shanghai Leukemia Cooperative Group Shanghai 200040 China.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954.
    Abstract:
    OBJECTIVE: To investigate the treatment outcome in newly diagnosed acute leukemia patients. METHODS: Two thousand five hundred and eighteen patients with acute leukemia registered in Shanghai were retrospectively analyzed. RESULTS: and CONCLUSIONS: The overall complete remission (CR) rate of acute leukemia was 60.4%: 51% for acute myeloid leukemia (AML) and 76.7% for acute lymphoid leukemia (ALL). CR rate of childhood ALL was 87.1%, while of elderly AML only 26%. Between 1984 and 1994, CR rates of AML and of ALL were not increased except for that of AML-M(3). Induction regimen was associated with CR rate. All-transretinoic acid was effective for AML-M(3). The VDLP and VDP regimens were more effective than that of VP regimen for ALL patients. There was no significant difference in CR rate between DA and HA regimens for treatment of ALL patients.
    [Abstract] [Full Text] [Related] [New Search]